HIV-1 integrase-DNA recognition mechanisms

Viruses

Volumn 1, Issue 3, 2009, Pages 713-736

  Kessl, Jacques J ^a   McKee, Christopher J ^a   Eidahl, Jocelyn O ^a   Shkriabai, Nikolozi ^a   Katz, Ari ^a   Kvaratskhelia, Mamuka ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Crosslinking; DNA; Footprinting; HIV; Integrase; Retroviruses

Indexed keywords

EID: 77957027357     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v1030713     Document Type: Review

References (134)

1. Brown, P.O. Integration. In Retroviruses; Coffin, J.M., Hughes, S.H., Varmus, H.E., Eds.; Cold Spring Harbor Laboratory: Plainview, NY, USA, 1997; pp. 161-204.
2. Grobler, J.A.; Stillmock, K.; Hu, B.; Witmer, M.; Felock, P.; Espeseth, A.S.; Wolfe, A.; Egbertson, M.; Bourgeois, M.; Melamed, J.; Wai, J.S.; Young, S.; Vacca, J.; Hazuda, D.J. Diketo acid inhibitor mechanism and HIV-1 integrase: Implications for metal binding in the active site of phosphotransferase enzymes. Proc. Natl. Acad. Sci. USA 2002, 99, 6661-6666.
3. Hazuda, D.J.; Felock, P.; Witmer, M.; Wolfe, A.; Stillmock, K.; Grobler, J.A.; Espeseth, A.; Gabryelski, L.; Schleif, W.; Blau, C.; Miller, M.D. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science 2000, 287, 646-650.
4. Summa, V.; Petrocchi, A.; Bonelli, F.; Crescenzi, B.; Donghi, M.; Ferrara, M.; Fiore, F.; Gardelli, C.; Gonzalez Paz, O.; Hazuda, D.J.; Jones, P.; Kinzel, O.; Laufer, R.; Monteagudo, E.; Muraglia, E.; Nizi, E.; Orvieto, F.; Pace, P.; Pescatore, G.; Scarpelli, R.; Stillmock, K.; Witmer, M.V.; Rowley, M. Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection. J. Med. Chem. 2008, 51, 5843-5855.
5. Llano, M.; Saenz, D.T.; Meehan, A.; Wongthida, P.; Peretz, M.; Walker, W.H.; Teo, W.; Poeschla, E.M. An essential role for LEDGF/p75 in HIV integration. Science 2006, 314, 461-464.
6. Lewinski, M.K.; Yamashita, M.; Emerman, M.; Ciuffi, A.; Marshall, H.; Crawford, G.; Collins, F.; Shinn, P.; Leipzig, J.; Hannenhalli, S.; Berry, C.C.; Ecker, J.R.; Bushman, F.D. Retroviral DNA integration: Viral and cellular determinants of target-site selection. PLoS Pathog. 2006, 2, e60.
7. Farnet, C.M.; Haseltine, W.A. Integration of human immunodeficiency virus type 1 DNA in vitro. Proc. Natl. Acad. Sci. USA 1990, 87, 4164-4168.
8. Bukrinsky, M.I.; Sharova, N.; McDonald, T.L.; Pushkarskaya, T.; Tarpley, W.G.; Stevenson, M. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl. Acad. Sci. USA 1993, 90, 6125-6129.
9. Buckman, J.S.; Bosche, W.J.; Gorelick, R.J. Human immunodeficiency virus type 1 nucleocapsid zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA. J. Virol. 2003, 77, 1469-1480.
10. Carteau, S.; Batson, S.C.; Poljak, L.; Mouscadet, J.F.; de Rocquigny, H.; Darlix, J.L.; Roques, B.P.; Kas, E.; Auclair, C. Human immunodeficiency virus type 1 nucleocapsid protein specifically stimulates Mg2+-dependent DNA integration in vitro. J. Virol. 1997, 71, 6225-6229.
11. Carteau, S.; Gorelick, R.J.; Bushman, F.D. Coupled integration of human immunodeficiency virus type 1 cDNA ends by purified integrase in vitro: Stimulation by the viral nucleocapsid protein. J. Virol. 1999, 73, 6670-6679.
12. Chen, H.; Engelman, A. The barrier-to-autointegration protein is a host factor for HIV type 1 integration. Proc. Natl. Acad. Sci. USA 1998, 95, 15270-15274.
13. Lee, M.S.; Craigie, R. A previously unidentified host protein protects retroviral DNA from autointegration. Proc. Natl. Acad. Sci. USA 1998, 95, 1528-1533.
14. Cherepanov, P.; Maertens, G.; Proost, P.; Devreese, B.; Van Beeumen, J.; Engelborghs, Y.; De Clercq, E.; Debyser, Z. HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J. Biol. Chem. 2003, 278, 372-381.
15. Shun, M.C.; Raghavendra, N.K.; Vandegraaff, N.; Daigle, J.E.; Hughes, S.; Kellam, P.; Cherepanov, P.; Engelman, A. LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev. 2007, 21, 1767-1778.
16. Engelman, A. Host cell factors and HIV-1 integration. Future HIV Ther. 2007, 1, 415-426.
17. Lee, M.S.; Craigie, R. Protection of retroviral DNA from autointegration: Involvement of a cellular factor. Proc. Natl. Acad. Sci. USA 1994, 91, 9823-9827.
18. Wu, W.; Henderson, L.E.; Copeland, T.D.; Gorelick, R.J.; Bosche, W.J.; Rein, A.; Levin, J.G. Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract. J. Virol. 1996, 70, 7132-7142.
19. Chen, H.; Wei, S.Q.; Engelman, A. Multiple integrase functions are required to form the native structure of the human immunodeficiency virus type I intasome. J. Biol. Chem. 1999, 274, 17358-17364.
20. Bowerman, B.; Brown, P.O.; Bishop, J.M.; Varmus, H.E. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev. 1989, 3, 469-478.
21. Brown, P.O.; Bowerman, B.; Varmus, H.E.; Bishop, J.M. Correct integration of retroviral DNA in vitro. Cell 1987, 49, 347-356.
22. Fujiwara, T.; Mizuuchi, K. Retroviral DNA integration: Structure of an integration intermediate. Cell 1988, 54, 497-504.
23. Ellison, V.; Abrams, H.; Roe, T.; Lifson, J.; Brown, P. Human immunodeficiency virus integration in a cell-free system. J. Virol. 1990, 64, 2711-2715.
24. Lee, Y.M.; Coffin, J.M. Efficient autointegration of avian retrovirus DNA in vitro. J. Virol. 1990, 64, 5958-5965.
25. Engelman, A. Isolation and analysis of HIV-1 preintegration complexes. Methods Mol. Biol. 2009, 485, 135-149.
26. Li, M.; Craigie, R. Processing of viral DNA ends channels the HIV-1 integration reaction to concerted integration. J. Biol. Chem. 2005, 280, 29334-29339.
27. Li, M.; Mizuuchi, M.; Burke, T.R., Jr.; Craigie, R. Retroviral DNA integration: Reaction pathway and critical intermediates. Embo J. 2006, 25, 1295-1304.
28. Li, M.; Craigie, R. Nucleoprotein complex intermediates in HIV-1 integration. Methods 2009, 47, 237-242.
29. Sinha, S.; Pursley, M.H.; Grandgenett, D.P. Efficient concerted integration by recombinant human immunodeficiency virus type 1 integrase without cellular or viral cofactors. J. Virol. 2002, 76, 3105-3113.
30. Pandey, K.K.; Sinha, S.; Grandgenett, D.P. Transcriptional coactivator LEDGF/p75 modulates human immunodeficiency virus type 1 integrase-mediated concerted integration. J. Virol. 2007, 81, 3969-3979.
31. Sinha, S.; Grandgenett, D.P. Recombinant human immunodeficiency virus type 1 integrase exhibits a capacity for full-site integration in vitro that is comparable to that of purified preintegration complexes from virus-infected cells. J. Virol. 2005, 79, 8208-8216.
32. Chow, S.A.; Vincent, K.A.; Ellison, V.; Brown, P.O. Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science 1992, 255, 723-726.
33. Delelis, O.; Parissi, V.; Leh, H.; Mbemba, G.; Petit, C.; Sonigo, P.; Deprez, E.; Mouscadet, J.F. Efficient and specific internal cleavage of a retroviral palindromic DNA sequence by tetrameric HIV-1 integrase. PLoS One 2007, 2, e608.
34. Delelis, O.; Carayon, K.; Saib, A.; Deprez, E.; Mouscadet, J.F. Integrase and integration: Biochemical activities of HIV-1 integrase. Retrovirology 2008, 5, 114.
35. Cai, M.; Zheng, R.; Caffrey, M.; Craigie, R.; Clore, G.M.; Gronenborn, A.M. Solution structure of the N-terminal zinc binding domain of HIV-1 integrase. Nat. Struct. Biol. 1997, 4, 567-577.
36. Dyda, F.; Hickman, A.B.; Jenkins, T.M.; Engelman, A.; Craigie, R.; Davies, D.R. Crystal structure of the catalytic domain of HIV-1 integrase: Similarity to other polynucleotidyl transferases. Science 1994, 266, 1981-1986.
37. Goldgur, Y.; Dyda, F.; Hickman, A.B.; Jenkins, T.M.; Craigie, R.; Davies, D.R. Three new structures of the core domain of HIV-1 integrase: An active site that binds magnesium. Proc. Natl. Acad. Sci. USA 1998, 95, 9150-9154.
38. Eijkelenboom, A.P.; Lutzke, R.A.; Boelens, R.; Plasterk, R.H.; Kaptein, R.; Hard, K. The DNAbinding domain of HIV-1 integrase has an SH3-like fold. Nat. Struct. Biol. 1995, 2, 807-810.
39. Lodi, P.J.; Ernst, J.A.; Kuszewski, J.; Hickman, A.B.; Engelman, A.; Craigie, R.; Clore, G.M.; Gronenborn, A.M. Solution structure of the DNA binding domain of HIV-1 integrase. Biochemistry 1995, 34, 9826-9833.
40. Chen, J.C.; Krucinski, J.; Miercke, L.J.; Finer-Moore, J.S.; Tang, A.H.; Leavitt, A.D.; Stroud, R.M. Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: A model for viral DNA binding. Proc. Natl. Acad. Sci. USA 2000, 97, 8233-8238.
41. Wang, J.Y.; Ling, H.; Yang, W.; Craigie, R. Structure of a two-domain fragment of HIV-1 integrase: Implications for domain organization in the intact protein. Embo J. 2001, 20, 7333-7343.
42. Goldgur, Y.; Craigie, R.; Cohen, G.H.; Fujiwara, T.; Yoshinaga, T.; Fujishita, T.; Sugimoto, H.; Endo, T.; Murai, H.; Davies, D.R. Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: A platform for antiviral drug design. Proc. Natl. Acad. Sci. USA 1999, 96, 13040-13043.
43. Bushman, F.D.; Engelman, A.; Palmer, I.; Wingfield, P.; Craigie, R. Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc. Natl. Acad. Sci. USA 1993, 90, 3428-3432.
44. Zheng, R.; Jenkins, T.M.; Craigie, R. Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. Proc. Natl. Acad. Sci. USA 1996, 93, 13659-13664.
45. Lee, S.P.; Xiao, J.; Knutson, J.R.; Lewis, M.S.; Han, M.K. Zn2+ promotes the self-association of human immunodeficiency virus type-1 integrase in vitro. Biochemistry 1997, 36, 173-180.
46. Engelman, A.; Craigie, R. Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J. Virol. 1992, 66, 6361-6369.
47. Hare, S.; Di Nunzio, F.; Labeja, A.; Wang, J.; Engelman, A.; Cherepanov, P. Structural basis for functional tetramerization of lentiviral integrase. PLoS Pathog. 2009, 5, e1000515.
48. McKee, C.J.; Kessl, J.J.; Shkriabai, N.; Dar, M.J.; Engelman, A.; Kvaratskhelia, M. Dynamic modulation of HIV-1 integrase structure and function by cellular lens epithelium-derived growth factor (LEDGF) protein. J. Biol. Chem. 2008, 283, 31802-31812.
49. Fayet, O.; Ramond, P.; Polard, P.; Prere, M.F.; Chandler, M. Functional similarities between retroviruses and the IS3 family of bacterial insertion sequences? Mol. Microbiol. 1990, 4, 1771-1777.
50. Kulkosky, J.; Jones, K.S.; Katz, R.A.; Mack, J.P.; Skalka, A.M. Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol. Cell. Biol. 1992, 12, 2331-2338.
51. Hazuda, D.J.; Wolfe, A.L.; Hastings, J.C.; Robbins, H.L.; Graham, P.L.; LaFemina, R.L.; Emini, E.A. Viral long terminal repeat substrate binding characteristics of the human immunodeficiency virus type 1 integrase. J. Biol. Chem. 1994, 269, 3999-4004.
52. Leavitt, A.D.; Robles, G.; Alesandro, N.; Varmus, H.E. Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J. Virol. 1996, 70, 721-728.
53. Yang, W.; Steitz, T.A. Recombining the structures of HIV integrase, RuvC and RNase H. Structure 1995, 3, 131-134.
54. Beese, L.S.; Steitz, T.A. Structural basis for the 3'-5' exonuclease activity of Escherichia coli DNA polymerase I: A two metal ion mechanism. Embo J. 1991, 10, 25-33.
55. Lins, R.D.; Straatsma, T.P.; Briggs, J.M. Similarities in the HIV-1 and ASV integrase active sites upon metal cofactor binding. Biopolymers 2000, 53, 308-315.
56. Robinson, H.; Gao, Y.G.; McCrary, B.S.; Edmondson, S.P.; Shriver, J.W.; Wang, A.H. The hyperthermophile chromosomal protein Sac7d sharply kinks DNA. Nature 1998, 392, 202-205.
57. Krueger, J.K.; McCrary, B.S.; Wang, A.H.; Shriver, J.W.; Trewhella, J.; Edmondson, S.P. The solution structure of the Sac7d/DNA complex: A small-angle X-ray scattering study. Biochemistry 1999, 38, 10247-10255.
58. Gao, Y.G.; Su, S.Y.; Robinson, H.; Padmanabhan, S.; Lim, L.; McCrary, B.S.; Edmondson, S.P.; Shriver, J.W.; Wang, A.H. The crystal structure of the hyperthermophile chromosomal protein Sso7d bound to DNA. Nat. Struct. Biol. 1998, 5, 782-786.
59. Lutzke, R.A.; Plasterk, R.H. Structure-based mutational analysis of the C-terminal DNA-binding domain of human immunodeficiency virus type 1 integrase: Critical residues for protein oligomerization and DNA binding. J. Virol. 1998, 72, 4841-4848.
60. Esposito, D.; Craigie, R. Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction. Embo J. 1998, 17, 5832-5843.
61. Zhao, Z.; McKee, C.J.; Kessl, J.J.; Santos, W.L.; Daigle, J.E.; Engelman, A.; Verdine, G.; Kvaratskhelia, M. Subunit-specific protein footprinting reveals significant structural rearrangements and a role for N-terminal Lys-14 of HIV-1 Integrase during viral DNA binding. J. Biol. Chem. 2008, 283, 5632-5641.
62. Bera, S.; Pandey, K.K.; Vora, A.C.; Grandgenett, D.P. Molecular Interactions between HIV-1 integrase and the two viral DNA ends within the synaptic complex that mediates concerted integration. J. Mol. Biol. 2009, 389, 183-198.
63. LaFemina, R.L.; Callahan, P.L.; Cordingley, M.G. Substrate specificity of recombinant human immunodeficiency virus integrase protein. J. Virol. 1991, 65, 5624-5630.
64. van Gent, D.C.; Elgersma, Y.; Bolk, M.W.; Vink, C.; Plasterk, R.H. DNA binding properties of the integrase proteins of human immunodeficiency viruses types 1 and 2. Nucleic Acids Res. 1991, 19, 3821-3827.
65. Smerdon, S.J.; Jager, J.; Wang, J.; Kohlstaedt, L.A.; Chirino, A.J.; Friedman, J.M.; Rice, P.A.; Steitz, T.A. Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 1994, 91, 3911-3915.
66. Bujacz, G.; Alexandratos, J.; Wlodawer, A.; Merkel, G.; Andrake, M.; Katz, R.A.; Skalka, A.M. Binding of different divalent cations to the active site of avian sarcoma virus integrase and their effects on enzymatic activity. J. Biol. Chem. 1997, 272, 18161-18168.
67. Gao, K.; Wong, S.; Bushman, F. Metal binding by the D, DX35E motif of human immunodeficiency virus type 1 integrase: Selective rescue of Cys substitutions by Mn2+ in vitro. J. Virol. 2004, 78, 6715-6722.
68. Hazuda, D.J.; Felock, P.J.; Hastings, J.C.; Pramanik, B.; Wolfe, A.L. Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase. J. Virol. 1997, 71, 7005-7011.
69. Lee, S.P.; Censullo, M.L.; Kim, H.G.; Han, M.K. Substrate-length-dependent activities of human immunodeficiency virus type 1 integrase in vitro: Differential DNA binding affinities associated with different lengths of substrates. Biochemistry 1995, 34, 10215-10223.
70. Yi, J.; Asante-Appiah, E.; Skalka, A.M. Divalent cations stimulate preferential recognition of a viral DNA end by HIV-1 integrase. Biochemistry 1999, 38, 8458-8468.
71. Vercammen, J.; Maertens, G.; Gerard, M.; De Clercq, E.; Debyser, Z.; Engelborghs, Y. DNA-induced polymerization of HIV-1 integrase analyzed with fluorescence fluctuation spectroscopy. J. Biol. Chem. 2002, 277, 38045-38052.
72. Brin, E.; Leis, J. HIV-1 integrase interaction with U3 and U5 terminal sequences in vitro defined using substrates with random sequences. J. Biol. Chem. 2002, 277, 18357-18364.
73. Renisio, J.G.; Cosquer, S.; Cherrak, I.; El Antri, S.; Mauffret, O.; Fermandjian, S. Pre-organized structure of viral DNA at the binding-processing site of HIV-1 integrase. Nucleic Acids Res. 2005, 33, 1970-1981.
74. Katz, R.A.; DiCandeloro, P.; Kukolj, G.; Skalka, A.M. Role of DNA end distortion in catalysis by avian sarcoma virus integrase. J. Biol. Chem. 2001, 276, 34213-34220.
75. Johnson, A.A.; Sayer, J.M.; Yagi, H.; Patil, S.S.; Debart, F.; Maier, M.A.; Corey, D.R.; Vasseur, J.J.; Burke, T.R., Jr.; Marquez, V.E.; Jerina, D.M.; Pommier, Y. Effect of DNA modifications on DNA processing by HIV-1 integrase and inhibitor binding: Role of DNA backbone flexibility and an open catalytic site. J. Biol. Chem. 2006, 281, 32428-32438.
76. Agapkina, J.; Smolov, M.; Barbe, S.; Zubin, E.; Zatsepin, T.; Deprez, E.; Le Bret, M.; Mouscadet, J.F.; Gottikh, M. Probing of HIV-1 integrase/DNA interactions using novel analogs of viral DNA. J. Biol. Chem. 2006, 281, 11530-11540.
77. Engelman, A.; Bushman, F.D.; Craigie, R. Identification of discrete functional domains of HIV-1 integrase and their organization within an active multimeric complex. Embo J. 1993, 12, 3269-3275.
78. van den Ent, F.M.; Vos, A.; Plasterk, R.H. Dissecting the role of the N-terminal domain of human immunodeficiency virus integrase by trans-complementation analysis. J. Virol. 1999, 73, 3176-3183.
79. van Gent, D.C.; Vink, C.; Groeneger, A.A.; Plasterk, R.H. Complementation between HIV integrase proteins mutated in different domains. Embo J. 1993, 12, 3261-3267.
80. Vincent, K.A.; Ellison, V.; Chow, S.A.; Brown, P.O. Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations. J. Virol. 1993, 67, 425-437.
81. Jenkins, T.M.; Engelman, A.; Ghirlando, R.; Craigie, R. A soluble active mutant of HIV-1 integrase: Involvement of both the core and carboxyl-terminal domains in multimerization. J. Biol. Chem. 1996, 271, 7712-7718.
82. Deprez, E.; Tauc, P.; Leh, H.; Mouscadet, J.F.; Auclair, C.; Brochon, J.C. Oligomeric states of the HIV-1 integrase as measured by time-resolved fluorescence anisotropy. Biochemistry 2000, 39, 9275-9284.
83. Deprez, E.; Barbe, S.; Kolaski, M.; Leh, H.; Zouhiri, F.; Auclair, C.; Brochon, J.C.; Le Bret, M.; Mouscadet, J.F. Mechanism of HIV-1 integrase inhibition by styrylquinoline derivatives in vitro. Mol. Pharmacol. 2004, 65, 85-98.
84. Baranova, S.; Tuzikov, F.V.; Zakharova, O.D.; Tuzikova, N.A.; Calmels, C.; Litvak, S.; Tarrago-Litvak, L.; Parissi, V.; Nevinsky, G.A. Small-angle X-ray characterization of the nucleoprotein complexes resulting from DNA-induced oligomerization of HIV-1 integrase. Nucleic Acids Res. 2007, 35, 975-987.
85. Faure, A.; Calmels, C.; Desjobert, C.; Castroviejo, M.; Caumont-Sarcos, A.; Tarrago-Litvak, L.; Litvak, S.; Parissi, V. HIV-1 integrase crosslinked oligomers are active in vitro. Nucleic Acids Res. 2005, 33, 977-986.
86. Guiot, E.; Carayon, K.; Delelis, O.; Simon, F.; Tauc, P.; Zubin, E.; Gottikh, M.; Mouscadet, J.F.; Brochon, J.C.; Deprez, E. Relationship between the oligomeric status of HIV-1 integrase on DNA and enzymatic activity. J. Biol. Chem. 2006, 281, 22707-22719.
87. Bao, K.K.; Wang, H.; Miller, J.K.; Erie, D.A.; Skalka, A.M.; Wong, I. Functional oligomeric state of avian sarcoma virus integrase. J. Biol. Chem. 2003, 278, 1323-1327.
88. Ren, G.; Gao, K.; Bushman, F.D.; Yeager, M. Single-particle image reconstruction of a tetramer of HIV integrase bound to DNA. J. Mol. Biol. 2007, 366, 286-294.
89. Heuer, T.S.; Brown, P.O. Photo-cross-linking studies suggest a model for the architecture of an active human immunodeficiency virus type 1 integrase-DNA complex. Biochemistry 1998, 37, 6667-6678.
90. Jenkins, T.M.; Esposito, D.; Engelman, A.; Craigie, R. Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking. Embo J. 1997, 16, 6849-6859.
91. Mazumder, A.; Neamati, N.; Pilon, A.A.; Sunder, S.; Pommier, Y. Chemical trapping of ternary complexes of human immunodeficiency virus type 1 integrase, divalent metal, and DNA substrates containing an abasic site. Implications for the role of lysine 136 in DNA binding. J. Biol. Chem. 1996, 271, 27330-27338.
92. Johnson, A.A.; Santos, W.; Pais, G.C.; Marchand, C.; Amin, R.; Burke, T.R., Jr.; Verdine, G.; Pommier, Y. Integration requires a specific interaction of the donor DNA terminal 5'-cytosine with glutamine 148 of the HIV-1 integrase flexible loop. J. Biol. Chem. 2006, 281, 461-467.
93. Heuer, T.S.; Brown, P.O. Mapping features of HIV-1 integrase near selected sites on viral and target DNA molecules in an active enzyme-DNA complex by photo-cross-linking. Biochemistry 1997, 36, 10655-10665.
94. Gao, K.; Butler, S.L.; Bushman, F. Human immunodeficiency virus type 1 integrase: Arrangement of protein domains in active cDNA complexes. Embo J. 2001, 20, 3565-3576.
95. Chen, A.; Weber, I.T.; Harrison, R.W.; Leis, J. Identification of amino acids in HIV-1 and avian sarcoma virus integrase subsites required for specific recognition of the long terminal repeat Ends. J. Biol. Chem. 2006, 281, 4173-4182.
96. Dolan, J.; Chen, A.; Weber, I.T.; Harrison, R.W.; Leis, J. Defining the DNA substrate binding sites on HIV-1 integrase. J. Mol. Biol. 2009, 385, 568-579.
97. Lu, R.; Limon, A.; Devroe, E.; Silver, P.A.; Cherepanov, P.; Engelman, A. Class II integrase mutants with changes in putative nuclear localization signals are primarily blocked at a postnuclear entry step of human immunodeficiency virus type 1 replication. J. Virol. 2004, 78, 12735-12746.
98. Lu, R.; Limon, A.; Ghory, H.Z.; Engelman, A. Genetic analyses of DNA-binding mutants in the catalytic core domain of human immunodeficiency virus type 1 integrase. J. Virol. 2005, 79, 2493-2505.
99. Asante-Appiah, E.; Skalka, A.M. A metal-induced conformational change and activation of HIV-1 integrase. J. Biol. Chem. 1997, 272, 16196-16205.
100. Puglia, J.; Wang, T.; Smith-Snyder, C.; Cote, M.; Scher, M.; Pelletier, J.N.; John, S.; Jonsson, C.B.; Roth, M.J. Revealing domain structure through linker-scanning analysis of the murine leukemia virus (MuLV) RNase H and MuLV and human immunodeficiency virus type 1 integrase proteins. J. Virol. 2006, 80, 9497-9510.
101. Bor, Y.C.; Miller, M.D.; Bushman, F.D.; Orgel, L.E. Target-sequence preferences of HIV-1 integration complexes in vitro. Virology 1996, 222, 283-288.
102. Goodarzi, G.; Chiu, R.; Brackmann, K.; Kohn, K.; Pommier, Y.; Grandgenett, D.P. Host site selection for concerted integration by human immunodeficiency virus type-1 virions in vitro. Virology 1997, 231, 210-217.
103. Fitzgerald, M.L.; Grandgenett, D.P. Retroviral integration: In vitro host site selection by avian integrase. J. Virol. 1994, 68, 4314-4321.
104. Carteau, S.; Hoffmann, C.; Bushman, F. Chromosome structure and human immunodeficiency virus type 1 cDNA integration: Centromeric alphoid repeats are a disfavored target. J. Virol. 1998, 72, 4005-4014.
105. Holman, A.G.; Coffin, J.M. Symmetrical base preferences surrounding HIV-1, avian sarcoma/leukosis virus, and murine leukemia virus integration sites. Proc. Natl. Acad. Sci. USA 2005, 102, 6103-6107.
106. Stevens, S.W.; Griffith, J.D. Sequence analysis of the human DNA flanking sites of human immunodeficiency virus type 1 integration. J. Virol. 1996, 70, 6459-6462.
107. Wu, X.; Li, Y.; Crise, B.; Burgess, S.M.; Munroe, D.J. Weak palindromic consensus sequences are a common feature found at the integration target sites of many retroviruses. J. Virol. 2005, 79, 5211-5214.
108. Ciuffi, A.; Bushman, F.D. Retroviral DNA integration: HIV and the role of LEDGF/p75. Trends Genet. 2006, 22, 388-395.
109. Engelman, A.; Cherepanov, P. The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication. PLoS Pathog. 2008, 4, e1000046.
110. Pruss, D.; Reeves, R.; Bushman, F.D.; Wolffe, A.P. The influence of DNA and nucleosome structure on integration events directed by HIV integrase. J. Biol. Chem. 1994, 269, 25031-25041.
111. Pruss, D.; Bushman, F.D.; Wolffe, A.P. Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core. Proc. Natl. Acad. Sci. USA 1994, 91, 5913-5917.
112. Katz, R.A.; Gravuer, K.; Skalka, A.M. A preferred target DNA structure for retroviral integrase in vitro. J. Biol. Chem. 1998, 273, 24190-24195.
113. Pryciak, P.M.; Sil, A.; Varmus, H.E. Retroviral integration into minichromosomes in vitro. Embo J. 1992, 11, 291-303.
114. Pryciak, P.M.; Varmus, H.E. Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection. Cell 1992, 69, 769-780.
115. Harper, A.L.; Skinner, L.M.; Sudol, M.; Katzman, M. Use of patient-derived human immunodeficiency virus type 1 integrases to identify a protein residue that affects target site selection. J. Virol. 2001, 75, 7756-7762.
116. Harper, A.L.; Sudol, M.; Katzman, M. An amino acid in the central catalytic domain of three retroviral integrases that affects target site selection in nonviral DNA. J. Virol. 2003, 77, 3838-3845.
117. Lutzke, R.A.; Vink, C.; Plasterk, R.H. Characterization of the minimal DNA-binding domain of the HIV integrase protein. Nucleic Acids Res. 1994, 22, 4125-4131.
118. Williams, K.L.; Zhang, Y.; Shkriabai, N.; Karki, R.G.; Nicklaus, M.C.; Kotrikadze, N.; Hess, S.; Le Grice, S.F.; Craigie, R.; Pathak, V.K.; Kvaratskhelia, M. Mass spectrometric analysis of the HIV-1 integrase-pyridoxal 5'-phosphate complex reveals a new binding site for a nucleotide inhibitor. J. Biol. Chem. 2005, 280, 7949-7955.
119. van Gent, D.C.; Groeneger, A.A.; Plasterk, R.H. Mutational analysis of the integrase protein of human immunodeficiency virus type 2. Proc. Natl. Acad. Sci. USA 1992, 89, 9598-9602.
120. Hare, S.; Shun, M.C.; Gupta, S.S.; Valkov, E.; Engelman, A.; Cherepanov, P. A novel co-crystal structure affords the design of gain-of-function lentiviral integrase mutants in the presence of modified PSIP1/LEDGF/p75. PLoS Pathog. 2009, 5, e1000259.
121. Raghavendra, N.K.; Engelman, A. LEDGF/p75 interferes with the formation of synaptic nucleoprotein complexes that catalyze full-site HIV-1 DNA integration in vitro: Implications for the mechanism of viral cDNA integration. Virology 2007, 360, 1-5.
122. Priet, S.; Gros, N.; Navarro, J.M.; Boretto, J.; Canard, B.; Querat, G.; Sire, J. HIV-1-associated uracil DNA glycosylase activity controls dUTP misincorporation in viral DNA and is essential to the HIV-1 life cycle. Mol. Cell 2005, 17, 479-490.
123. De Rijck, J.; Vandekerckhove, L.; Gijsbers, R.; Hombrouck, A.; Hendrix, J.; Vercammen, J.; Engelborghs, Y.; Christ, F.; Debyser, Z. Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication. J. Virol. 2006, 80, 11498-11509.
124. Cherepanov, P. LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro. Nucleic Acids Res. 2007, 35, 113-124.
125. De Luca, L.; Vistoli, G.; Pedretti, A.; Barreca, M.L.; Chimirri, A. Molecular dynamics studies of the full-length integrase-DNA complex. Biochem. Biophys. Res. Commun. 2005, 336, 1010-1016.
126. Karki, R.G.; Tang, Y.; Burke, T.R., Jr.; Nicklaus, M.C. Model of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug design. J. Comput. Aided Mol. Des. 2004, 18, 739-760.
127. Podtelezhnikov, A.A.; Gao, K.; Bushman, F.D.; McCammon, J.A. Modeling HIV-1 integrase complexes based on their hydrodynamic properties. Biopolymers 2003, 68, 110-120.
128. Wielens, J.; Crosby, I.T.; Chalmers, D.K. A three-dimensional model of the human immunodeficiency virus type 1 integration complex. J. Comput. Aided Mol. Des. 2005, 19, 301-317.
129. Michel, F.; Crucifix, C.; Granger, F.; Eiler, S.; Mouscadet, J.F.; Korolev, S.; Agapkina, J.; Ziganshin, R.; Gottikh, M.; Nazabal, A.; Emiliani, S.; Benarous, R.; Moras, D.; Schultz, P.; Ruff, M. Structural basis for HIV-1 DNA integration in the human genome, role of the LEDGF/P75 cofactor. Embo J. 2009, 28, 980-991.
130. Steiniger-White, M.; Rayment, I.; Reznikoff, W.S. Structure/function insights into Tn5 transposition. Curr. Opin. Struct. Biol. 2004, 14, 50-57.
131. Alian, A.; Griner, S.L.; Chiang, V.; Tsiang, M.; Jones, G.; Birkus, G.; Geleziunas, R.; Leavitt, A.D.; Stroud, R.M. Catalytically-active complex of HIV-1 integrase with a viral DNA substrate binds anti-integrase drugs. Proc. Natl. Acad. Sci. USA 2009, 106, 8192-8197.
132. Valkov, E.; Gupta, S.S.; Hare, S.; Helander, A.; Roversi, P.; McClure, M.; Cherepanov, P. Functional and structural characterization of the integrase from the prototype foamy virus. Nucleic Acids Res. 2009, 37, 243-255.
133. Botbol, Y.; Raghavendra, N.K.; Rahman, S.; Engelman, A.; Lavigne, M. Chromatinized templates reveal the requirement for the LEDGF/p75 PWWP domain during HIV-1 integration in vitro. Nucleic Acids Res. 2008, 36, 1237-1246.
134. Kessl, J.J.; Eidahl, J.O.; Shkriabai, N.; Zhao, Z.; McKee, C.J.; Hess, S.; Burke, T.R., Jr.; Kvaratskhelia, M. An allosteric mechanism for inhibiting HIV-1 integrase with a small molecule. Mol. Pharmacol. 2009, 76, 824-832.